Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 80

Sort by

Sort Order Select

Journal Articles

Venetoclax and dexamethasone synergize with inotuzumab ozogamicin–induced DNA damage signaling in B-lineage ALL

Hanna Kirchhoff, Uemran Karsli, Caroline Schoenherr, Karin Battmer, Sergej Erschow, Steven R. Talbot, Doris Steinemann, Michael Heuser, Olaf Heidenreich, Denise Hilfiker-Kleiner, Arnold Ganser, Matthias Eder, Michaela Scherr

Blood (2021) 137 (19): 2657–2661.

https://doi.org/10.1182/blood.2020008544

Published: 2021

Includes: Supplemental data

Journal Articles

R-Loops-Induced ATR Signaling As a Potential Therapeutic Target in Myelodysplastic Syndrome

Johann-Christoph Jann, Johanna Flach, PhD, Antje Knaflic, Eva Altrock, PhD, Nanni Schmitt, MSc, Alexander Streuer, Justine Danner, Franziska Hofmann, Verena Nowak, Nina Draeger, Julia Obländer, Iris Palme, Patrick Wuchter, MD, Ahmed Jawhar, MD, Georgia Metzgeroth, MD, Florian Nolte, MD, Wolf-Karsten Hofmann, MD PhD, Daniel Nowak, MD

Blood (2019) 134 (Supplement_1): 4218.

https://doi.org/10.1182/blood-2019-126431

Published: 2019

Journal Articles

Yet another susceptibility variant for ALL: what’s next?

Kjeld Schmiegelow

Blood (2019) 133 (7): 628–629.

https://doi.org/10.1182/blood-2018-12-891564

Published: 2019

Journal Articles

Multiomic Insights into Novel Treg Subset

Oktay Kirak, MD PhD, Eugene Ke, Mohsen Sabouri-Ghomi, Justin R. Abadejos, Brent Freeman, Amy Nham, Nathaniel Phillips, Manching Ku, PhD

Blood (2018) 132 (Supplement 1): 863.

https://doi.org/10.1182/blood-2018-99-118101

Published: 2018

Journal Articles

Somatic MDC1 Mutation in Putative Pre-Leukaemic Stem Cell of a Biclonal Case of Chronic Lymphocytic Leukaemia

Anya K Hotinski, BSc, BMBS, FRACP, FRCPA, Karen M Lower, BSc (Hons), PhD GradCertEd (HighEd), Bryone J. Kuss, PhD BMBS, FRCPA, FRACP

Blood (2018) 132 (Supplement 1): 5534.

https://doi.org/10.1182/blood-2018-99-115704

Published: 2018

Journal Articles

Diagnostic Challenges in the Era of Genomic Sequencing and Newborn Screening

Jennifer Puck, MD

Blood (2017) 130 (Supplement 1): SCI-30.

https://doi.org/10.1182/blood.V130.Suppl_1.SCI-30.SCI-30

Published: 2017

Journal Articles

USP7 inhibition alters homologous recombination repair and targets CLL cells independently of ATM/p53 functional status

Blood (2017) 130 (2): 156–166.

https://doi.org/10.1182/blood-2016-12-758219

Published: 2017

Includes: Supplemental data

Journal Articles

ANKHD1 Silencing Delays S Phase Progression in Multiple Myeloma Cells Via Activation of ATM/ATR -CDC25a Pathway

Dhyani Anamika, Patricia Favaro, PhD, Sara Teresinha Olalla Saad, MD PhD

Blood (2016) 128 (22): 5624.

https://doi.org/10.1182/blood.V128.22.5624.5624

Published: 2016

Journal Articles

The In Vivo Recovery/Survivaland Pharmacokinetic Properties of Dexamethasone Sodium Phosphate Encapsulated in Autologous Erythrocytes

Shodeinde Coker, MDMSc, Zbigniew M Szczepiorkowski, MD PhD FCAP, Alan H. Seigel, MD, Antonio Ferrari, MD PhD MBA, Luca Benatti, Giovanni Mambrini, BS, Ravi Anand, MD, Richard D. Hartman, PhD, Larry J. Dumont, PhD MBA

Blood (2016) 128 (22): 2629.

https://doi.org/10.1182/blood.V128.22.2629.2629

Published: 2016

Journal Articles

Inhibition of ATR in Combination with Nucleoside Analogues Eradicates Acute Myeloid Leukaemia in an Orthotopic Murine Xenograft Model

Sarah E Fordham, PhD, Helen J Blair, PhD, Claire J Elstob, PhD, Deepali Pal, PhD, Nicola Curtin, PhD, Paul Milne, PhD, Matthew Collin, MD PhD, Graham H Jackson, MD MBBS, Helen J Marr, MD PhD, Olaf Heidenreich, PhD, Ruth Plummer, John Pollard, PhD, Tobias F. Menne, MD PhD FRCPath, Gail L Jones, MD BMBS, James M Allan, DPhil

Blood (2016) 128 (22): 4031.

https://doi.org/10.1182/blood.V128.22.4031.4031

Published: 2016

Journal Articles

A New Murine Model for B Cell Malignancies on ATM-Deficient Background Reveals Involvement of Multiple Pathogenic Mechanisms

Tegan A Francis, PhD, Nicholas J Davies, PhD, Michael John Griffiths, BSc, Angelo Agathanggelou, PhD, Maha Ibrahim, Paul G. Murray, PhD, Zbigniew Rudzki, Tatjana Stankovic, MD PhD, Alexander M R Taylor, PhD

Blood (2016) 128 (22): 4093.

https://doi.org/10.1182/blood.V128.22.4093.4093

Published: 2016

Journal Articles

Perturbed hematopoiesis in mice lacking ATMIN

Fernando Anjos-Afonso, Joanna I. Loizou, Amy Bradburn, Nnennaya Kanu, Sukhveer Purewal, Clive Da Costa, Dominique Bonnet, Axel Behrens

Blood (2016) 128 (16): 2017–2021.

https://doi.org/10.1182/blood-2015-09-672980

Published: 2016

Includes: Supplemental data

Journal Articles

ANKHD1 Is Essential for Repair of DNA Double-Strand Breaks in Multiple Myeloma

Anamika Dhyani, PhD, Patricia Favaro, PhD, Sara T. Olalla Saad, MD, PhD

Blood (2015) 126 (23): 1762.

https://doi.org/10.1182/blood.V126.23.1762.1762

Published: 2015

Journal Articles

Mini-Chromosome Maintenance (MCM) DNA Helicase Genes Influence Acute Myeloid Leukemia (AML) Replication and Response to Chemotherapy-Induced DNA Damage

Joe Chin-Sun Huang, MD, Julia Sidorova, PhD, Sylvia Chien, Jin Dai, Ben Logsdon, PhD, Su-In Lee, PhD, Raymond J Monnat, MD, Pamela S. Becker, MD PhD

Blood (2015) 126 (23): 3629.

https://doi.org/10.1182/blood.V126.23.3629.3629

Published: 2015

Journal Articles

Aberrant TCRδ rearrangement underlies the T-cell lymphocytopenia and t(12;14) translocation associated with ATM deficiency

Wenxia Jiang, Brian J. Lee, Chen Li, Richard L. Dubois, Monica Gostissa, Frederick W. Alt, Shan Zha

Blood (2015) 125 (17): 2665–2668.

https://doi.org/10.1182/blood-2015-01-622621

Published: 2015

Includes: Supplemental data

Journal Articles

Disparate Requirements for the Phosphorylation of Distinct Sites on the Fanconi Anemia Group I Protein

Ronald S. Cheung, MD PhD, Maria Castella, PhD, Toshiyasu Taniguchi, MD PhD

Blood (2014) 124 (21): 358.

https://doi.org/10.1182/blood.V124.21.358.358

Published: 2014

Journal Articles

Histological Characteristics of Ataxia Telangiectasia Associated Lymphoproliferative Diseases. Results of the French Registry of Primary Immune Deficiencies

Danielle Canioni, MD, Nizar Mahlaoui, MD MSc, MPH, Chantal Andriamanga, MD, Catherine Dubois d'Enghien, Jean-Philippe Jais, MD PhD, Alain Fischer, MD PhD, Olivier Hermine, MD PhD, Nicole Brousse, Dominique Stoppa-Lyonnet, Felipe Suarez, MD PhD

Blood (2014) 124 (21): 1634.

https://doi.org/10.1182/blood.V124.21.1634.1634

Published: 2014

Journal Articles

Lymphoma Patients Secondary to Congenital and Acquired Immunodeficiency Syndroms in a Turkish Pediatric Oncology Center

Nurdan Tacyildiz, Prof, MD, Gulsah Tanyildiz, MD, Gulsan Yavuz, PROF , MD, Emel Unal, MD PROF, Handan Dincaslan, MD, Derya Ozyoruk, Zulfukar Gordu, MD, Aydan Ikinciogullari, POF, MD, Dogu Figen, PROF, MD, Gurses Sahin, MD

Blood (2014) 124 (21): 5445.

https://doi.org/10.1182/blood.V124.21.5445.5445

Published: 2014

Journal Articles

Combined Inhibition of mTOR and DNA-PK Blocks Survival, Adhesion, Proliferation and Chemoresistance in Primary Chronic Lymphocytic Leukemia (CLL) Cells

Rachel Thijssen, Gregor van Bochove, Ingrid AM Derks, Johanna ter Burg, Martin FM de Rooij, Marcel Spaargaren, PhD, Marie Jose Kersten, MD PhD, Eric Eldering, PhD, Arnon P. Kater, MD PhD

Blood (2014) 124 (21): 1981.

https://doi.org/10.1182/blood.V124.21.1981.1981

Published: 2014

Journal Articles

Perturbed Hematopoiesis In Mice Lacking ATMIN (an ATM co-Factor)

Fernando Anjos-Afonso, MSc. PhD., Joanna Loizou, PhD, Dominique Bonnet, PhD, Axel Behrens, PhD

Blood (2013) 122 (21): 2412.

https://doi.org/10.1182/blood.V122.21.2412.2412

Published: 2013

NARROW

Venetoclax and dexamethasone synergize with inotuzumab ozogamicin–induced DNA damage signaling in B-lineage ALL

R-Loops-Induced ATR Signaling As a Potential Therapeutic Target in Myelodysplastic Syndrome

Yet another susceptibility variant for ALL: what’s next?

Multiomic Insights into Novel Treg Subset

Somatic MDC1 Mutation in Putative Pre-Leukaemic Stem Cell of a Biclonal Case of Chronic Lymphocytic Leukaemia

Diagnostic Challenges in the Era of Genomic Sequencing and Newborn Screening

USP7 inhibition alters homologous recombination repair and targets CLL cells independently of ATM/p53 functional status

ANKHD1 Silencing Delays S Phase Progression in Multiple Myeloma Cells Via Activation of ATM/ATR -CDC25a Pathway

The In Vivo Recovery/Survivaland Pharmacokinetic Properties of Dexamethasone Sodium Phosphate Encapsulated in Autologous Erythrocytes

Inhibition of ATR in Combination with Nucleoside Analogues Eradicates Acute Myeloid Leukaemia in an Orthotopic Murine Xenograft Model

A New Murine Model for B Cell Malignancies on ATM-Deficient Background Reveals Involvement of Multiple Pathogenic Mechanisms

Perturbed hematopoiesis in mice lacking ATMIN

ANKHD1 Is Essential for Repair of DNA Double-Strand Breaks in Multiple Myeloma

Mini-Chromosome Maintenance (MCM) DNA Helicase Genes Influence Acute Myeloid Leukemia (AML) Replication and Response to Chemotherapy-Induced DNA Damage

Aberrant TCRδ rearrangement underlies the T-cell lymphocytopenia and t(12;14) translocation associated with ATM deficiency

Disparate Requirements for the Phosphorylation of Distinct Sites on the Fanconi Anemia Group I Protein

Histological Characteristics of Ataxia Telangiectasia Associated Lymphoproliferative Diseases. Results of the French Registry of Primary Immune Deficiencies

Lymphoma Patients Secondary to Congenital and Acquired Immunodeficiency Syndroms in a Turkish Pediatric Oncology Center

Combined Inhibition of mTOR and DNA-PK Blocks Survival, Adhesion, Proliferation and Chemoresistance in Primary Chronic Lymphocytic Leukemia (CLL) Cells

Perturbed Hematopoiesis In Mice Lacking ATMIN (an ATM co-Factor)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only